Jaume Mora
Impact in
- Neurology top 0.5%
- Neuroblastoma Research and Treatments
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 91
- Neuroblastoma Research and Treatments 81
-
- Cancer therapeutics and mechanisms 13
- Renal and related cancers 9
- Co-authors
- William L. Gerald (22 shared papers)Carmen de Torres (40 shared papers)Nai‐Kong V. Cheung (25 shared papers)Manel Esteller (6 shared papers)Carlos Cordon‐Cardo (2 shared papers)Cinzia Lavarino (34 shared papers)W. Richard McCombie (1 shared paper)David Polsky (1 shared paper)
- Journals
- Journal of Clinical Oncology (13 papers)Cancers (10 papers)Pediatric Blood & Cancer (10 papers)Oncotarget (7 papers)Cancer (6 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Jaume Mora
205 papers receiving 5.5k citations
Jaume Mora's Hit Papers
Peers
Comparison fields: 5 of 124
- Neurology 1.2k
- Cancer Research 824
- Genetics 525
- Oncology 1.0k
- Molecular Biology 2.7k
Countries citing papers authored by Jaume Mora
This map shows the geographic impact of Jaume Mora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Mora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Mora more than expected).
Fields of papers citing papers by Jaume Mora
This network shows the impact of papers produced by Jaume Mora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Mora. The network helps show where Jaume Mora may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaume Mora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 213 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inactivation of the apoptosis effector Apaf-1 in malignant melanoma Hit paper breakdown → | 2001 | 769 |
| 2 | 2007 | 398 | |
| 3 | 2017 | 356 | |
| 4 | 2012 | 269 | |
| 5 | 2005 | 119 | |
| 6 | 2018 | 117 | |
| 7 | Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature | 2001 | 106 |
| 8 | 2001 | 98 | |
| 9 | 1999 | 93 | |
| 10 | 2020 | 84 | |
| 11 | 2015 | 73 | |
| 12 | 2014 | 72 | |
| 13 | Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. | 2001 | 68 |
| 14 | Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. | 2003 | 66 |
| 15 | 2010 | 65 | |
| 16 | 2009 | 65 | |
| 17 | 2018 | 64 | |
| 18 | 2016 | 64 | |
| 19 | 1999 | 58 | |
| 20 | 2010 | 53 |
About Jaume Mora
Jaume Mora is a scholar working on Neurology, Molecular Biology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 213 papers that have together received 5.6k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (81 papers), Cancer, Hypoxia, and Metabolism (29 papers), Sarcoma Diagnosis and Treatment (25 papers), Glioma Diagnosis and Treatment (17 papers), Cancer therapeutics and mechanisms (13 papers), Lung Cancer Research Studies (11 papers), Renal and related cancers (9 papers) and Ocular Oncology and Treatments (9 papers). The work is most often cited by research in Neurology (1.2k citations), Cancer Research (824 citations), Genetics (525 citations), Oncology (1.0k citations) and Molecular Biology (2.7k citations). Jaume Mora has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include William L. Gerald, Carmen de Torres, Nai‐Kong V. Cheung, Manel Esteller, Carlos Cordon‐Cardo, Cinzia Lavarino, W. Richard McCombie, David Polsky, Marı́a S. Soengas and Scott W. Lowe. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Pediatric Blood & Cancer, Oncotarget and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.